AzTrials
AzTrials

Preterm BirthNCT01601886

Delivery Room Practice Change Following the Initiation of the NICHD SUPPORT Trial

An observational study of Preterm Birth, run by Luc Brion at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study was designed to analyze whether initiation of the NICHD Neonatal Research Network SUPPORT trial was followed by a change in frequency of endotracheal intubation the delivery room in non-participants and whether these changes were associated with changes in management and outcomes. Read more about this study

Who is it for?
Ages 24 to 35 weeks
Conditions the study is for
Preterm Birth
How many people
3,843 participants
Where
1 siteUnited States
Study dates
Apr 2008to Apr 2012
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 24 to 35 weeks
  • All sexes
  • No healthy volunteers
  • Child

Study population: All babies born at Parkland Memorial Hospital with gestational age at least 24 weeks and less than 35 weeks between 01/2003 and 06/2010

Who may be able to join

  • All babies born at Parkland Memorial Hospital with gestational age at least 24 weeks and less than 35 weeks between 01/2003 and 06/2010

Who cannot join

  • Infants receiving comfort care
  • Those with major congenital anomalies
  • Those enrolled in the SUPPORT trial

Trial locations and contacts

1 site in 1 country.

United States1 site
  • University of Texas Southwestern

    Dallas, Texas, 75390-9063

Other trials in United States

About this study

This study was designed to analyze whether initiation of the NICHD Neonatal Research Network SUPPORT trial was followed by a change in frequency of endotracheal intubation the delivery room in non-participants and whether these changes were associated with changes in management and outcomes.

The investigators hypothesized that the investigators would observe following the initiation of the SUPPORT trial a 33% reduction in the rate of intubation in the delivery room among non-participants preterm infants at Parkland Memorial Hospital.

Conditions
Preterm Birth
Keywords
Intubation, Intratracheal, Continuous Positive Airway Pressure, Historical Cohort Studies, Clinical Trial
Medical subject headings
Premature Birth

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT01601886
Study groupRoleWhat they receive
Before SUPPORT01/03-06/05
During SUPPORT recruitment07/05-02/09
After SUPPORT03/09-06/10

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Endotracheal intubation in the delivery room

    Frequency of endotracheal intubation in the delivery room

    Measured: In the delivery room (1 day)

Secondary outcomes (12)
  1. Continuous positive airway pressure in the delivery room

    Frequency of continuous positive airway pressure in the delivery room

    Measured: In the delivery room (1 day)

  2. Endotracheal intubation in the first four hours after admission

    Frequency of endotracheal intubation in the first fours after admission to the neonatal intensive care unit

    Measured: First four hours after admission

  3. Endotracheal intubation until four hours after admission

    Frequency of endotracheal intubation between birth and four hours after admission in the neonatal intensive care unit

    Measured: Between birth and 4 hours after admission

  4. Admninistration of surfactant

    Frequency of admninistration of surfactant any time between birth and 2 days of age

    Measured: Any time between birth and 2 days of age

  5. Pneumothorax

    Pneumothorax any time before discharge or transfer or 12 months of age (whichever comes first)

    Measured: Any time before discharge or transfer or 12 months of age (whichever comes first)

  6. Bronchopulmonary dysplasia

    Chronic changes on chest radiograph and oxygen requirement (fractional inspiratory concentration of oxygen greater than 0.21) for at least 28 days

    Measured: 28 days

  7. Necrotizing enterocolitis

    Necrotizing enterocolitis (at least stage II, modified Bell's classification) any time before discharge or transfer or 12 months of age (whichever comes first)

    Measured: Any time before discharge or transfer or 12 months of age (whichever comes first)

  8. Duration of mechanical ventilation

    Duration of invasive mechanical ventilation until discharge or transfer or or 12 months of age (whichever comes first)

    Measured: Until discharge or transfer or 12 months of age (whichever comes first)

  9. Maximum oxygen concentration

    Maximum inspiratory oxygen concentration until discharge or transfer or 12 months of age (whichever comes first)

    Measured: Until discharge or transfer or 12 months of age (whichever comes first)

  10. Severe retinopathy of prematurity

    Severe retinopathy of prematurity (at least stage III, international classification) until discharge or transfer or 12 months of age (whichever comes first)

    Measured: Until discharge or transfer or 12 months of age (whichever comes first)

  11. Mortality

    Mortality until discharge or transfer or 12 months of age (whichever comes first)

    Measured: Until discharge or transfer or 12 months of age (whichever comes first)

  12. Severe brain lesion on imaging

    Cystic periventricular leukomalacia or grade III or IV intraventricular/ periventricular hemorrhage detected by ultrasonogram any time before discharge or transfer or 12 months of age (whichever comes first)

    Measured: Any time before discharge or transfer or 12 months of age (whichever comes first)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 May 2012 (estimated)
  2. Study startApr 2008
  3. Primary completionNov 2011
  4. Study completionApr 2012

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Retrospective
Enrolment
3,843 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01601886
Sponsor's protocol ID
STU 092010-201
Other IDs
Velos 12121
Status last verified
May 2012
First submitted
15 May 2012
Last updated
18 May 2012
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

An observational study of Preterm Birth, run by Luc Brion at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 18 May 2012. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Endotracheal intubation in the delivery room (time frame: In the delivery room (1 day)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 May 2012.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in